Increased rituximab exposure does not improve response and outcome of patients with chronic lymphocytic leukemia after fludarabine, cyclophosphamide, rituximab. A French Innovative Leukemia Organization (FILO) study

Authors :: Frédérique Orsini-Piocelle
Alain Delmer
Olivier Tournilhac
Stéphane Leprêtre
Rémi Letestu
Mira Tout
Thérèse Aurran
David Ternant
Sophie de Guibert
Phan Letuan
Emmanuelle Ferrant
Valérie Rouille
Guillaume Cartron
Bruno Villemagne
Pierre Feugier
Boris Guiu
Caroline Dartigeas
Anne Banos
Beatrice Mahe
Jehan Dupuis
Anne-Laure Gagez
Veronique Leblond
Role of intra-Clonal Heterogeneity and Leukemic environment in ThErapy Resistance of chronic leukemias (CHELTER)
Université Clermont Auvergne [2017-2020] (UCA [2017-2020])
Source :: Haematologica, Haematologica, Ferrata Storti Foundation, 2018, 103 (8), pp.e356-e359. ⟨10.3324/haematol.2017.182352⟩, Haematologica, 2018, 103 (8), pp.e356-e359. ⟨10.3324/haematol.2017.182352⟩
Publication Year :: 2018
Publisher :: HAL CCSD, 2018.
Abstract: International audience

Language :: English
ISSN :: 03906078 and 15928721
Database :: OpenAIRE
Journal :: Haematologica, Haematologica, Ferrata Storti Foundation, 2018, 103 (8), pp.e356-e359. ⟨10.3324/haematol.2017.182352⟩, Haematologica, 2018, 103 (8), pp.e356-e359. ⟨10.3324/haematol.2017.182352⟩
Accession number :: edsair.doi.dedup.....e9b090a6f26e5cda242977db101f8c46
Full Text :: https://doi.org/10.3324/haematol.2017.182352⟩

Full Text Access

Tools